| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2114353
Max Phase: Preclinical
Molecular Formula: C9H12N5O4P
Molecular Weight: 285.20
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Nc1nc2c(ncn2CC/C=C\P(=O)(O)O)c(=O)[nH]1
Standard InChI: InChI=1S/C9H12N5O4P/c10-9-12-7-6(8(15)13-9)11-5-14(7)3-1-2-4-19(16,17)18/h2,4-5H,1,3H2,(H2,16,17,18)(H3,10,12,13,15)/b4-2-
Standard InChI Key: IKFPRPWLVDJMBV-RQOWECAXSA-N
Associated Targets(non-human)
Visna-maedi virus 44 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 285.20 | Molecular Weight (Monoisotopic): 285.0627 | AlogP: -0.22 | #Rotatable Bonds: 4 |
| Polar Surface Area: 147.12 | Molecular Species: ACID | HBA: 6 | HBD: 4 |
| #RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 3.62 | CX Basic pKa: 0.51 | CX LogP: -1.87 | CX LogD: -4.19 |
| Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.57 | Np Likeness Score: 0.19 |
References
| 1. Harnden MR, Parkin A, Parratt MJ, Perkins RM.. (1993) Novel acyclonucleotides: synthesis and antiviral activity of alkenylphosphonic acid derivatives of purines and a pyrimidine., 36 (10): [PMID:8496903] [10.1021/jm00062a006] |
Source
Source(1):